Dr Timothy John Sullivan Iii, MD - Medicare Allergy/immunology in Ogden, UT

Dr Timothy John Sullivan Iii, MD is a medicare enrolled "Allergy & Immunology - Allergy" physician in Ogden, Utah. He went to University Of Miami, Lm Miller School Of Medicine and graduated in 1966 and has 58 years of diverse experience with area of expertise as Allergy/immunology. He is a member of the group practice Vicki J Lyons Md Pc and his current practice location is 4403 Harrison Blvd., Ste 4640, Ogden, Utah. You can reach out to his office (for appointments etc.) via phone at (801) 387-4850.

Dr Timothy John Sullivan Iii is licensed to practice in Utah (license number 8263858-1205) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1023012911.

Contact Information

Dr Timothy John Sullivan Iii, MD
4403 Harrison Blvd., Ste 4640,
Ogden, UT 84403-3304
(801) 387-4850
(801) 387-4855



Physician's Profile

Full NameDr Timothy John Sullivan Iii
GenderMale
SpecialityAllergy/immunology
Experience58 Years
Location4403 Harrison Blvd., Ogden, Utah
Accepts Medicare AssignmentsYes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Dr Timothy John Sullivan Iii attended and graduated from University Of Miami, Lm Miller School Of Medicine in 1966
  NPI Data:
  • NPI Number: 1023012911
  • Provider Enumeration Date: 06/08/2005
  • Last Update Date: 06/03/2015
  Medicare PECOS Information:
  • PECOS PAC ID: 7214052802
  • Enrollment ID: I20130320000742

Medical Identifiers

Medical identifiers for Dr Timothy John Sullivan Iii such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1023012911NPI-NPPES
00570996CMedicaidGA
00570996FMedicaidGA

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
207KA0200XAllergy & Immunology - Allergy 037913 (Georgia)Secondary
207KA0200XAllergy & Immunology - Allergy 8263858-1205 (Utah)Primary

Medical Facilities Affiliation

Facility NameLocationFacility Type
Mckay Dee HospitalOgden, UTHospital

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
Vicki J Lyons Md Pc44865585664

News Archive

Preventing bleeding is key to the treatment of acute coronary syndromes

On Monday, September 4 and Tuesday, September 5 at the World Congress of Cardiology, Dr. Christopher Granger presented data stressing the importance of prevention of bleeding as a key objective in treatment of acute coronary syndromes.

Focus on GHI principles necessary to ensure success of U.S. global health programs

Noting that the Global Health Initiative (GHI) leadership and the three core entities of GHI - USAID, the Centers for Disease Control and Prevention (CDC) and PEPFAR - announced the closure of the GHI office and an end to the initiative's current phase on July 3, Serra Sippel, president of the Center for Health and Gender Equity, writes in the Huffington Post's "Politics" blog that "the three agencies will be responsible for ensuring that the GHI principles are implemented in the field to achieve global health goals."

Study focuses on hormone-sensitive breast tumours

Gene expression in breast cancer provides valuable biological information for better determining the diagnosis, treatment, risk of relapse and survival rate. However, the most common form of characterizing breast cancer is by histopathological techniques. This study, headed by Dr Aleix Prat, Head of the Translational Genomics Group at the Vall d'Hebron Institute of Oncology (VHIO) and an oncologist at the Breast Cancer Unit of the Vall d´Hebron University Hospital, focused on hormone-sensitive breast tumours known as luminals.

Oxygen-deprived tumor cells have survival advantage that promotes metastasis

Using cells from human breast cancers and mouse breast cancer models, researchers at the Johns Hopkins Kimmel Cancer Center say they have significant new evidence that tumor cells exposed to low-oxygen conditions have an advantage when it comes to invading and surviving in the bloodstream.

Birch bark compound may be potent prostate cancer fighter

A compound found in the bark of the white birch tree - betulonic acid, a derivative of betulinol - may finally have been rendered a water-soluble, bio-available drug, and is already showing the potential to be a possible agent against prostate cancer - in cell culture and in an animal model.

Read more Medical News

› Verified 7 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Dr Timothy John Sullivan Iii allows following entities to bill medicare on his behalf.
Entity NameVicki J Lyons Md Pc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1780716563
PECOS PAC ID: 4486558566
Enrollment ID: O20031120000760

News Archive

Preventing bleeding is key to the treatment of acute coronary syndromes

On Monday, September 4 and Tuesday, September 5 at the World Congress of Cardiology, Dr. Christopher Granger presented data stressing the importance of prevention of bleeding as a key objective in treatment of acute coronary syndromes.

Focus on GHI principles necessary to ensure success of U.S. global health programs

Noting that the Global Health Initiative (GHI) leadership and the three core entities of GHI - USAID, the Centers for Disease Control and Prevention (CDC) and PEPFAR - announced the closure of the GHI office and an end to the initiative's current phase on July 3, Serra Sippel, president of the Center for Health and Gender Equity, writes in the Huffington Post's "Politics" blog that "the three agencies will be responsible for ensuring that the GHI principles are implemented in the field to achieve global health goals."

Study focuses on hormone-sensitive breast tumours

Gene expression in breast cancer provides valuable biological information for better determining the diagnosis, treatment, risk of relapse and survival rate. However, the most common form of characterizing breast cancer is by histopathological techniques. This study, headed by Dr Aleix Prat, Head of the Translational Genomics Group at the Vall d'Hebron Institute of Oncology (VHIO) and an oncologist at the Breast Cancer Unit of the Vall d´Hebron University Hospital, focused on hormone-sensitive breast tumours known as luminals.

Oxygen-deprived tumor cells have survival advantage that promotes metastasis

Using cells from human breast cancers and mouse breast cancer models, researchers at the Johns Hopkins Kimmel Cancer Center say they have significant new evidence that tumor cells exposed to low-oxygen conditions have an advantage when it comes to invading and surviving in the bloodstream.

Birch bark compound may be potent prostate cancer fighter

A compound found in the bark of the white birch tree - betulonic acid, a derivative of betulinol - may finally have been rendered a water-soluble, bio-available drug, and is already showing the potential to be a possible agent against prostate cancer - in cell culture and in an animal model.

Read more Medical News

› Verified 7 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Timothy John Sullivan Iii is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Dr Timothy John Sullivan Iii, MD
4403 Harrison Blvd., Ste 4640,
Ogden, UT 84403-3304

Ph: (801) 387-4850
Dr Timothy John Sullivan Iii, MD
4403 Harrison Blvd., Ste 4640,
Ogden, UT 84403-3304

Ph: (801) 387-4850

News Archive

Preventing bleeding is key to the treatment of acute coronary syndromes

On Monday, September 4 and Tuesday, September 5 at the World Congress of Cardiology, Dr. Christopher Granger presented data stressing the importance of prevention of bleeding as a key objective in treatment of acute coronary syndromes.

Focus on GHI principles necessary to ensure success of U.S. global health programs

Noting that the Global Health Initiative (GHI) leadership and the three core entities of GHI - USAID, the Centers for Disease Control and Prevention (CDC) and PEPFAR - announced the closure of the GHI office and an end to the initiative's current phase on July 3, Serra Sippel, president of the Center for Health and Gender Equity, writes in the Huffington Post's "Politics" blog that "the three agencies will be responsible for ensuring that the GHI principles are implemented in the field to achieve global health goals."

Study focuses on hormone-sensitive breast tumours

Gene expression in breast cancer provides valuable biological information for better determining the diagnosis, treatment, risk of relapse and survival rate. However, the most common form of characterizing breast cancer is by histopathological techniques. This study, headed by Dr Aleix Prat, Head of the Translational Genomics Group at the Vall d'Hebron Institute of Oncology (VHIO) and an oncologist at the Breast Cancer Unit of the Vall d´Hebron University Hospital, focused on hormone-sensitive breast tumours known as luminals.

Oxygen-deprived tumor cells have survival advantage that promotes metastasis

Using cells from human breast cancers and mouse breast cancer models, researchers at the Johns Hopkins Kimmel Cancer Center say they have significant new evidence that tumor cells exposed to low-oxygen conditions have an advantage when it comes to invading and surviving in the bloodstream.

Birch bark compound may be potent prostate cancer fighter

A compound found in the bark of the white birch tree - betulonic acid, a derivative of betulinol - may finally have been rendered a water-soluble, bio-available drug, and is already showing the potential to be a possible agent against prostate cancer - in cell culture and in an animal model.

Read more News

› Verified 7 days ago


Allergy & Immunology Doctors in Ogden, UT

Vicki J Lyons, M.D.
Allergy & Immunology
Medicare: Accepting Medicare Assignments
Practice Location: 4403 Harrison Blvd, Suite 4640, Ogden, UT 84403
Phone: 801-387-4850    Fax: 801-387-4855
Dr. Joseph Robert Anderson Jr., M.D.
Allergy & Immunology
Medicare: Not Enrolled in Medicare
Practice Location: 5929 Fashion Point Dr, Suite 101, Ogden, UT 84403
Phone: 801-476-0052    Fax: 801-476-0064
Dr. Charles Mitchell Rogers, M.D.
Allergy & Immunology
Medicare: Not Enrolled in Medicare
Practice Location: 4403 Harrison Blvd Ste 4640, Ogden, UT 84403
Phone: 801-387-4850    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.